| Dr Gedion Atnafu, MD | |
|
12701 Truths Promise Ct, Bowie, MD 20720-5600 | |
| (410) 650-4100 | |
| (877) 648-1188 |
| Full Name | Dr Gedion Atnafu |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 21 Years |
| Location | 12701 Truths Promise Ct, Bowie, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326006578 | NPI | - | NPPES |
| 647076-01 | Other | MD | BLUE CROSS/BLUE SHIELD |
| 408456000 | Medicaid | MD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medstar Southern Maryland Hospital Center | Clinton, MD | Hospital |
| Medstar Franklin Square Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
| Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Ependymomas are the second most frequent type of malignant brain tumor in children. Ependymoma develops from precursor cells of the tissue that lines the hollow cavities of the brain. Therapy results of ependymoma vary immensely: While in some patients tumor growth comes to a standstill after surgery and radiotherapy, in other children the disease rapidly takes a severe course.
Building upon years of research, a new study from Children's Hospital of Philadelphia (CHOP) has demonstrated how a specific assessment of the eye could someday help properly diagnosis and monitor concussions.
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
› Verified 6 days ago
| Entity Name | University Of Maryland Physicians P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689623175 PECOS PAC ID: 2769394808 Enrollment ID: O20031105000792 |
News Archive
Ependymomas are the second most frequent type of malignant brain tumor in children. Ependymoma develops from precursor cells of the tissue that lines the hollow cavities of the brain. Therapy results of ependymoma vary immensely: While in some patients tumor growth comes to a standstill after surgery and radiotherapy, in other children the disease rapidly takes a severe course.
Building upon years of research, a new study from Children's Hospital of Philadelphia (CHOP) has demonstrated how a specific assessment of the eye could someday help properly diagnosis and monitor concussions.
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
› Verified 6 days ago
| Entity Name | Maryland General Clinical Practice Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770684805 PECOS PAC ID: 8123926649 Enrollment ID: O20041109000226 |
News Archive
Ependymomas are the second most frequent type of malignant brain tumor in children. Ependymoma develops from precursor cells of the tissue that lines the hollow cavities of the brain. Therapy results of ependymoma vary immensely: While in some patients tumor growth comes to a standstill after surgery and radiotherapy, in other children the disease rapidly takes a severe course.
Building upon years of research, a new study from Children's Hospital of Philadelphia (CHOP) has demonstrated how a specific assessment of the eye could someday help properly diagnosis and monitor concussions.
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
› Verified 6 days ago
| Entity Name | Grace Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326629619 PECOS PAC ID: 0446216832 Enrollment ID: O20041207001105 |
News Archive
Ependymomas are the second most frequent type of malignant brain tumor in children. Ependymoma develops from precursor cells of the tissue that lines the hollow cavities of the brain. Therapy results of ependymoma vary immensely: While in some patients tumor growth comes to a standstill after surgery and radiotherapy, in other children the disease rapidly takes a severe course.
Building upon years of research, a new study from Children's Hospital of Philadelphia (CHOP) has demonstrated how a specific assessment of the eye could someday help properly diagnosis and monitor concussions.
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
› Verified 6 days ago
| Entity Name | Medstar Medical Group Ii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000347 |
News Archive
Ependymomas are the second most frequent type of malignant brain tumor in children. Ependymoma develops from precursor cells of the tissue that lines the hollow cavities of the brain. Therapy results of ependymoma vary immensely: While in some patients tumor growth comes to a standstill after surgery and radiotherapy, in other children the disease rapidly takes a severe course.
Building upon years of research, a new study from Children's Hospital of Philadelphia (CHOP) has demonstrated how a specific assessment of the eye could someday help properly diagnosis and monitor concussions.
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gedion Atnafu, MD 7845 Oakwood Rd, Ste 105, Glen Burnie, MD 21061-4256 Ph: (410) 650-4100 | Dr Gedion Atnafu, MD 12701 Truths Promise Ct, Bowie, MD 20720-5600 Ph: (410) 650-4100 |
News Archive
Ependymomas are the second most frequent type of malignant brain tumor in children. Ependymoma develops from precursor cells of the tissue that lines the hollow cavities of the brain. Therapy results of ependymoma vary immensely: While in some patients tumor growth comes to a standstill after surgery and radiotherapy, in other children the disease rapidly takes a severe course.
Building upon years of research, a new study from Children's Hospital of Philadelphia (CHOP) has demonstrated how a specific assessment of the eye could someday help properly diagnosis and monitor concussions.
For nearly two years, University of Michigan neurologist Eva Feldman , M.D., Ph.D. has led the nation's first clinical trial of stem cell injections in patients with the deadly degenerative disease known as amyotrophic lateral sclerosis, often called ALS or Lou Gehrig 's disease.
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data presented on Tuesday, November 3, 2009 at the 51st American Society for Therapeutic Radiology and Oncology (ASTRO) annual meeting in Chicago, Illinois.
› Verified 6 days ago
Dr. Mariam Mcconnell Bahrami, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4379 Northview Dr, Bowie, MD 20716 Phone: 301-262-2627 Fax: 301-262-8411 | |
Dr. Sara Dereath Collins, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 16900 Science Dr Ste 200, Bowie, MD 20715 Phone: 410-573-9805 | |
Bai Kanu, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 3233 Superior Ln, B 21, Bowie, MD 20715 Phone: 301-805-2500 Fax: 301-805-0114 | |
Sobhan A Mathew, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3048 Mitchellville Rd, Bowie, MD 20716 Phone: 301-218-1456 Fax: 301-218-1462 | |
Dr. David L Siegel, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 14999 Health Center Dr, Ste 201, Bowie, MD 20716 Phone: 301-262-8188 Fax: 301-464-8233 | |
Lizy Bose Thomas, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 14999 Health Center Dr, Suite 201, Bowie, MD 20716 Phone: 301-262-8188 Fax: 301-464-8233 | |
Dr. Edwin Shadzeka, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4314 Rustling Leaves Ter, Bowie, MD 20716 Phone: 301-806-2461 |